COVID-19 Vaccine for Young Kids Could Be Ready This Month

National Public Radio: Morning Edition | Peter Granitz & Rob Stein

Having a safe and effective vaccine available for children in this age group is a priority for the agency and we’re committed to a timely review of the data.

Granitz and Stein discuss a new vaccine regimen for children between six months to five years old from Pfizer-BioNTech. The new protocol could be authorized for emergency use by the FDA much earlier than anticipated.

Read more from NPR.